The Cooper Companies, Inc. (NASDAQ:COO) Shares Acquired by Deutsche Bank AG

Key Points

• Deutsche Bank AG increased its holdings in The Cooper Companies, Inc. by 10.3% during the first quarter, now owning approximately 0.64% of the company valued at $108.15 million.
• Cooper Companies reported $1 billion in revenue for its last quarter, exceeding the analyst consensus estimate and marking a 6.3% year-over-year increase in revenue.
• Analysts give Cooper Companies a consensus rating of "Moderate Buy" with an average price target of $96.73; recent price targets from brokerages range from $76.00 to $100.00.

Deutsche Bank AG grew its position in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 10.3% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 1,282,152 shares of the medical device company's stock after acquiring an additional 119,278 shares during the quarter. Deutsche Bank AG owned about 0.64% of Cooper Companies worth $108,150,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. City Holding Co. acquired a new stake in shares of Cooper Companies in the first quarter valued at about $34,000. Covestor Ltd grew its stake in shares of Cooper Companies by 35.5% in the fourth quarter. Covestor Ltd now owns 458 shares of the medical device company's stock valued at $42,000 after buying an additional 120 shares in the last quarter. Larson Financial Group LLC grew its stake in shares of Cooper Companies by 1,071.0% in the first quarter. Larson Financial Group LLC now owns 726 shares of the medical device company's stock valued at $61,000 after buying an additional 664 shares in the last quarter. HM Payson & Co. grew its stake in shares of Cooper Companies by 147.4% in the first quarter. HM Payson & Co. now owns 893 shares of the medical device company's stock valued at $75,000 after buying an additional 532 shares in the last quarter. Finally, UMB Bank n.a. grew its stake in shares of Cooper Companies by 16.7% in the first quarter. UMB Bank n.a. now owns 902 shares of the medical device company's stock valued at $76,000 after buying an additional 129 shares in the last quarter. 24.39% of the stock is currently owned by institutional investors and hedge funds.

Cooper Companies Stock Performance

NASDAQ:COO traded down $1.26 during trading hours on Thursday, reaching $73.01. 337,296 shares of the stock were exchanged, compared to its average volume of 2,158,409. The company has a quick ratio of 1.23, a current ratio of 2.10 and a debt-to-equity ratio of 0.30. The firm has a 50 day simple moving average of $71.86 and a 200-day simple moving average of $79.46. The Cooper Companies, Inc. has a 52 week low of $65.00 and a 52 week high of $112.38. The stock has a market capitalization of $14.60 billion, a P/E ratio of 35.46, a P/E/G ratio of 1.77 and a beta of 1.00.

Cooper Companies (NASDAQ:COO - Get Free Report) last released its earnings results on Thursday, May 29th. The medical device company reported $0.96 EPS for the quarter, topping analysts' consensus estimates of $0.93 by $0.03. Cooper Companies had a return on equity of 9.60% and a net margin of 10.39%. The company had revenue of $1 billion for the quarter, compared to the consensus estimate of $995.12 million. During the same quarter last year, the business posted $0.85 EPS. Cooper Companies's quarterly revenue was up 6.3% compared to the same quarter last year. As a group, sell-side analysts forecast that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Analysts Set New Price Targets

COO has been the subject of a number of recent research reports. Robert W. Baird lowered their target price on Cooper Companies from $107.00 to $97.00 and set an "outperform" rating for the company in a research note on Friday, May 30th. Mizuho lowered their target price on Cooper Companies from $105.00 to $90.00 and set an "outperform" rating for the company in a research note on Wednesday, July 16th. Wall Street Zen downgraded Cooper Companies from a "buy" rating to a "hold" rating in a report on Saturday, July 12th. Wells Fargo & Company reduced their price target on Cooper Companies from $118.00 to $93.00 and set an "overweight" rating for the company in a report on Friday, May 30th. Finally, Loop Capital set a $100.00 price target on Cooper Companies in a report on Tuesday, June 17th. Three analysts have rated the stock with a hold rating, nine have given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, Cooper Companies currently has an average rating of "Moderate Buy" and an average price target of $96.73.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.